Enteric Disease Testing Market Size to Surpass USD 8.09 Billion

Source Domain: www.openpr.com

The global enteric disease testing market is projected to exceed USD 8.09 billion by 2035, growing from USD 4.30 billion in 2025 at a CAGR of 6.52%.
Key growth drivers include the rising prevalence of gastrointestinal infections and advancements in diagnostic technologies.
Artificial intelligence (AI) plays a critical role in sample analysis acceleration, accuracy enhancement, and dataset management for epidemiological insights.
Major market segments include bacterial, viral, and parasitic enteric diseases, with bacterial segments leading the market.
Regional analysis indicates North America’s dominant market share, driven by regulatory frameworks and technological advancements, while Asia Pacific exhibits the fastest growth due to rising disease prevalence and healthcare investments.
Top companies include Abbott Laboratories, Becton, Dickinson and Company (BD), bioMérieux SA, and others focusing on molecular tests, immunoassays, and molecular diagnostics platforms.

You may have missed